Award
NIH Reporter #5UG3CA290312-03
Developing ribosome biogenesis inhibitors for the prevention of cancer
Recipient
UT SOUTHWESTERN MEDICAL CENTER
Award Amount
$292,886.00
Ceiling
$292,886.00
Awarded
May 14, 2026
Identifier
5UG3CA290312-03
Award to UT Southwestern Medical Center by the National Cancer Institute to develop ribosome biogenesis inhibitors for cancer prevention, with a total funding of $292,886.
Description
This project aims to develop inhibitors of ribosome biogenesis to prevent liver cancer. It involves screening natural product libraries and testing in mouse models. The project is funded by the National Cancer Institute and has a total award amount of $292,886 for the fiscal year 2026.